Ask a doctor about a prescription for ANESTOPIC 25 mg/g + 25 mg/g CREAM
Package Leaflet: Information for the Patient
ANESTOPIC 25 mg/g + 25 mg/g cream
Lidocaine/Prilocaine
Read the entire package leaflet carefully before starting to use this medication, as it contains important information for you.
Contents of the Package Leaflet
ANESTOPIC contains two active substances called lidocaine and prilocaine. They belong to a group of medications called local anesthetics.
ANESTOPIC works by temporarily numbing the surface of the skin. It is applied to the skin before certain medical procedures. It helps to stop pain in the skin; however, you may still feel sensations such as pressure and touch.
Adults, Adolescents, and Children
It can be used to numb the skin before:
Adults and Adolescents
It can also be used:
The use of ANESTOPIC on the genitals should be supervised by a doctor or nurse.
Adults
It can also be used to numb the skin before:
Do not useANESTOPIC
Warnings and Precautions
Consult your doctor or pharmacist before starting to use ANESTOPIC
Due to the potentially greater absorption through freshly shaved skin, it is essential to respect the recommended dose, skin surface, and application time.
Avoid contact of ANESTOPIC with the eyes, as it may cause irritation. If it accidentally enters your eye, you should rinse it immediately with warm water or saline solution (sodium chloride solution). Be careful not to apply anything to the eye until sensitivity returns.
ANESTOPIC should not be applied to a damaged eardrum.
When using ANESTOPIC before being vaccinated with live vaccines (e.g., tuberculosis vaccine), revisit your doctor or nurse after the required follow-up period for the vaccination result.
Children and Adolescents
In infants and newborns under 3 months, "methemoglobinemia" is frequently observed, a transient and clinically insignificant increase in blood pigment levels, up to 12 hours after application of ANESTOPIC.
Clinical studies could not confirm the efficacy of ANESTOPIC when blood is drawn from the heel of newborns or to provide adequate analgesia during circumcision.
ANESTOPIC should not be applied to the genital mucosa (e.g., in the vagina) of children (under 12 years) because there is insufficient data on the absorption of the active substances.
ANESTOPIC should not be used in children under 12 months of age who are simultaneously receiving treatment with other medications that affect the levels of the blood pigment "methemoglobin" (e.g., sulfonamides, see also section 2, "Using ANESTOPIC with other medications").
ANESTOPIC should not be used in premature newborns.
Using ANESTOPIC with other medications
Tell your doctor or pharmacist if you are using or have recently used or might use any other medications, including those obtained without a prescription and herbal medications. This is because ANESTOPIC may affect the way other medications work, and other medications may have an effect on ANESTOPIC.
In particular, inform your doctor or pharmacist if you or your child have recently used or received treatment with any of the following medications:
Pregnancy, Breastfeeding, and Fertility
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medication.
Occasional use of ANESTOPIC during pregnancy is unlikely to have any adverse effect on the fetus.
The active substances of ANESTOPIC (lidocaine and prilocaine) are excreted in breast milk. However, the amount is so small that it generally poses no risk to the child.
Animal studies have shown that there are no alterations in male or female fertility.
Driving and Using Machines
ANESTOPIC does not affect the ability to drive and use machines, or the effect is negligible, when used at the recommended doses.
ANESTOPIC contains macrogolglycerol hydroxystearate
This medication may cause skin reactions because it contains macrogolglycerol hydroxystearate.
Follow the instructions for administration of this medication exactly as indicated by your doctor, pharmacist, or nurse. If in doubt, consult your doctor, pharmacist, or nurse again.
Using ANESTOPIC
Do not use ANESTOPIC on the following areas:
People who frequently apply or remove the cream should ensure they avoid contact to prevent the appearance of hypersensitivity.
The protective membrane of the tube is pierced by pressing the cap onto it.
Use on the skin before minor interventions (such as needle puncture or minor skin procedures):
The usual dose for adults and adolescents over 12 years is 2 g (grams).
When applying the cream yourself, it is very important to follow the following instructions:
Use on extensive areas of freshly shaved skin before outpatient procedures (such as hair removal techniques):
The usual dose is 1 g of cream per 10 cm² (10 square centimeters) of skin surface, applied between 1 and 5 hours under a dressing. ANESTOPIC should not be used on a freshly shaved skin area larger than 600 cm² (600 square centimeters, e.g., 30 cm by 20 cm). The maximum dose is 60 g.
Use on the skin before hospital procedures (such as skin grafts) that require deeper skin anesthesia:
Use on the skin to remove wart-like lesions called "molluscum"
Use on the skin of the genitals before injecting local anesthetics
ANESTOPIC can be used in this way only in adults and adolescents over 12 years.
Use on the genitals before minor skin surgery (wart removal)
Use on leg ulcers before cleaning or removing damaged skin
If you use more ANESTOPIC than you should
If you use more ANESTOPIC than your doctor, pharmacist, or nurse has indicated, contact one of them immediately, even if you do not have symptoms. You can also call the Toxicology Information Service, phone 91.562.04.20, indicating the medication and the amount used.
The following symptoms may occur if you use too much ANESTOPIC. It is unlikely that these symptoms will appear if you follow the recommended use of ANESTOPIC.
In severe cases of overdose, symptoms may include seizures, low blood pressure, slow breathing, cessation of breathing, and alteration of heart rhythm. These effects can be potentially fatal.
If you have any doubts about the use of this medication, ask your doctor, pharmacist, or nurse.
Like all medications, this medication can cause side effects, although not everyone will experience them.
Contact your doctor or pharmacist if any of the following side effects bother you or do not seem to go away. Inform your doctor of anything else that makes you feel unwell while using ANESTOPIC.
A mild reaction (pallor or redness of the skin, slight swelling, burning, or initial itching) may appear in the area where ANESTOPIC is applied. These are normal reactions to the cream and anesthetics and will disappear soon without needing to take any action.
If you experience any unpleasant or unusual effect while using ANESTOPIC, stop using it and consult your doctor or pharmacist as soon as possible.
Common(may affect up to 1 in 10 people)
Uncommon(may affect up to 1 in 100 people)
Rare(may affect up to 1 in 1,000 people)
Other side effects in children
Methemoglobinemia, a blood disorder that is more frequently observed in newborns and infants from 0 to 12 months, often associated with overdose.
Reporting side effects
If you experience any side effects, consult your doctor, pharmacist, or nurse, even if they are not listed in this package leaflet. You can also report them directly through the Spanish Medication Monitoring System for Human Use: https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medication.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date stated on the carton and tube after "EXP". The expiration date is the last day of the month indicated.
Do not refrigerate or freeze.
Do not use ANESTOPIC if you notice any signs of deterioration.
Medications should not be disposed of via wastewater or household waste. Deposit the packaging and any unused medication in the SIGRE collection point at the pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and any unused medication. This will help protect the environment.
Composition ofANESTOPIC
AppearanceANESTOPICand container content
This medication is presented in boxes containing 1 tube with 30 g of cream.
Marketing authorization holder and manufacturer
Mesoestetic Pharma Group, S.L.
C/Tecnología, 25
08840 Viladecans- Barcelona- SPAIN
Date of the last revision of this prospectus:09/2015.
Detailed and updated information on this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for ANESTOPIC 25 mg/g + 25 mg/g CREAM – subject to medical assessment and local rules.